|
|
|
| Drug Delivery Markets: Oral Delivery |
|
| Table of Contents Published: 2009/07 Published by: Kalorama Information |
| Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there' s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend th ... |
| Nucleic Acid Amplification Dashboard, Series Two, July 2009 |
|
| Table of Contents Published: 2009/07 Published by: Percepta Associates Inc. |
| Nucleic acid amplification is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene expression. The Nucleic A ... |
| Proteomics: Technologies and Global Markets |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued at $4.1 billion in 2008 a ... |
| Pharmacogenomics: Delivering on the Promise |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ... |
| Next-Generation Sequencing: Solving the Genome |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. ... |
| Global In Vitro Diagnostic Market Analysis |
|
| Table of Contents Published: 2009/06 Published by: RNCOS E-Services Pvt. Ltd. |
| The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient ... |
| 2008/2009 Healthcare Research Review |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| BCC Research has provided comprehensive coverage of healthcare technology markets for many years, and we are now in the process of increasing our production of healthcare-related technology market research reports. This review of healthcare research condu ... |
| Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provide ... |
| Key Trends Fueling the Boom in Genetic Testing |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| Progress aptly describes the expanding field of genetic testing. The field is more than finding linkages of genes with diseases: it encompasses technologies that have made it easier to quickly and more efficiently discover genetic markers that predict dis ... |
| Biosimilars Series: Forecast Analysis |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and immine ... |
| Synthetic Biology: Emerging Global Markets |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013. ... |
| Therapeutic Monoclonal Antibodies Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ... |
| Stem Cell Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods tha ... |
| Point of Care Diagnostic Testing World Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| This TriMark Publications report describes latest developments in the point of care diagnostic testing (POCT) market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emerge ... |
| Point of Care Diagnostic Testing Sector Trends |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, comm ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Clinical Bundle |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The Clinical Bundle includes 4 reports within clinical laboratory analysis. ... |
| Genetics Bundle |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The Genetics Bundlel includes 8 reports based on the genetic markets. ... |
| Clinical Immunoanalyzer Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immunoanalyzer ... |
| Clinical Chemistry Analyzers |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small mol ... |
| Nucleic Acid Purification Dashboard, Series 2, June 2009 |
|
| Table of Contents Published: 2009/06 Published by: Percepta Associates Inc. |
| Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. ... |
| European Biological Wastewater Treatment Systems Market |
|
| Table of Contents Published: 2009/05 Published by: Frost & Sullivan |
| This research service looked at the biological wastewater treatment market in Europe. A regional market profile was provided, which included a review of the biological wastewater treatment systems market in each region, analysing the key market forces of ... |
| Monoclonal Antibodies in Cancer Therapy 2009-2024 |
|
| Table of Contents Published: 2009/05 Published by: Visiongain |
| Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ... |
| Approaches to Reducing Phase II Attrition |
|
| Table of Contents Published: 2009/05 Published by: Insight Pharma Reports |
| Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ... |
| US Markets for ENT and Bronchoscopy Devices 2009 |
|
| Table of Contents Published: 2009/05 Published by: Millennium Research Group |
| The US markets for ear, nose, and throat (ENT) and bronchoscopy devices will grow moderately through 2013. The ENT market will be far larger than the market for bronchoscopy devices and will also expand more rapidly, reaching a value of more than $360 mil ... |
|
|
|
View Cart
Top